Julien Delpech

TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France.

VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.

INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.

Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.

Doctoconsult SAS operates an online portal, which provides telemedecine services. It specializes in mental health. The company was founded by Grevent Fanny Jacq in 2016 and is headquartered in Fresnes, France.

ISAI Gestion SAS (ISAI) is a network of business angels established in 2008 and headquartered in Paris. The fund was founded by Pierre Morizet-Kosciusko, Ouriel Ohayon, Geoffroy Roux de Bezieux, Stephane Treppoz. ISAI's active investors are entrepreneurs. Individuals connected with the active investors also provide capital without getting involved in operations. The firm manages a tax-advantaged investment vehicle designed for high-net worth individuals. ISAI's name derives from a Japanese Kanji conveying uniqueness, and also stands for International Society of Angel Investors.

Innobio FCPI seeks investment opportunities in companies located in France. The fund focuses on innovative technology products and services in the healthcare market. It provides financing for early stage capital requirements and can invest between EUR 3 and EUR 10 million per target.

CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL.

Quitoque SA offers food delivery services. It provides meal subscription and packages. The company was founded by Etienne Georges Boix, Céline Nguyen, and Laurie Périé in 2014 and is headquartered in Paris, France.

Wind Venture SAS (Wind Capital) is a venture capital firm founded in 2010 by Xavier Gury and Thierry Vandewalle. The firm is headquartered in Paris, France.

HOSPIMEDIA SASU operates an online platform for the medical sector. The firm provides daily news service for and recruitment in the hospital and healthcare sector. Its services encompass subscriptions on social and/or social health, Staffsante, and Staffsocial, which act as go-betweens linking recruiters and job seekers. The company was founded by Ronan Denoual, Christian Nicoli and Julien Sibierski on September 13, 2001 and is headquartered in Lille, France.

A-Volute SAS engages in the design and development of audio processing software. Its product, under the brand of Nahimic suite, offers features for boosting volume, voice clarity, and virtual surround, as well as frequency leveling, noise reduction, and high-definition recording. The company was founded by Hong Cong Tuyên Pham and Ambroise Recht in 2004 and is headquartered in Nord, France.

GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

Comuto SA operates an online platform for carpooling. It provides its users insurance coverage. The company was founded by Frédéric Mazzella, Francis Nappez, and Nicolas Brusson on September 20, 2006 and is headquartered in Paris, France.

impak Finance, Inc. operates as a Canadian FinTech company focusing on driving the social impact economy. The company was founded by Paul Allard, Tima Gros, Stephane Dumont, Andy Krupski, Armen Ouzounian, Jean Oulhen, Philippe Gablain, Jean-Francois Pelland and Kosta Kostic and is headquartered in 2016 and is headquartered in Toronto, Canada.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Olympyk SAS is a French company that offers online access to thousands of races, including 5k, 10k, half-marathon, marathon, trail running, ultra-trail, and Nordic walking. The company is based in Lille, France. The company's mission is to help people find their next challenge and provide them with a platform to do so. Olympyk was founded by Pierre-Yves Aubert, François-Xavier Le Louarn, Maxime Delaporte, and Ronan Denoual.